Correlation between MIB1-determined tumor growth fraction and incidence of tumor recurrence in early ovarian carcinomas.

Abstract:

PURPOSE:The decision concerning adjuvant therapy remains difficult in patients with very early stage ovarian carcinomas [Fédération Internationale de Gynécologie et d' Obstétrique (FIGO) Ia/b]. Therefore, we compared the MIB1-determined tumor growth fraction in archival tumor tissue with tumor recurrence and outcome of disease, and in relationship to other stages and clinical and morphological findings. PATIENTS AND METHODS:Ninety-two patients were followed in early stages of ovarian carcinomas (FIGO I and II) with no tumor residuals and were analyzed for tumor recurrences and long-term overall survival (mean 6.0 years, median 5.5). Fifty-eight patients had stage I tumors, among these were 38 in the sub-stages Ia/b. Tumor growth fraction (MIB1) in tissues from primary surgery was compared with the status of patients and disease, histology, and immunohistochemistry for carcinoembryonic antigen (CEA), CA125, CA153, steroid hormone receptors, and angiogenesis (chisquare test, Kaplan-Meier and discriminant analyses). RESULTS:Tumor-associated deaths occurred in 27 cases, tumor recurrences occurred in 35 cases. In contrast to the advanced stages of disease, the MIB1-determined tumor growth fraction outweighted all other parameters in the prediction of the course of disease (p < 0.001), followed by tumor grading (p = 0.001) and FIGO-substages (p = 0.026) in this retrospective study. Particularly in the very early stages, MIB1 predicted tumor recurrences in 84% of the cases (p < 0.001). Recurrences were not observed below a tumor growth fraction of 10% but prevailed in cases of more than 15%. CONCLUSION:Our data suggest MIB1 as an interesting additional tool for the decision of adjuvant therapy in patients with very early stages of ovarian carcinomas, which should be tested in prospective trials.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Münstedt K,von Georgi R,Franke FE

doi

10.1081/cnv-120030206

subject

Has Abstract

pub_date

2004-01-01 00:00:00

pages

185-94

issue

2

eissn

0735-7907

issn

1532-4192

journal_volume

22

pub_type

杂志文章
  • Triple-negative breast cancer: unique biology and its management.

    abstract::Triple-negative breast cancer is defined by the lack of expression of estrogen-receptor, progesterone-receptor, and HER-2/neu. It primarily, but not exclusively, carries the basal-like molecular profile on gene expression arrays and is associated with BRCA-1 and p53 mutations. It has an aggressive behavior and predile...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2010.483507

    authors: Maegawa RO,Tang SC

    更新日期:2010-10-01 00:00:00

  • Detection of Promoter DNA Methylation of APC, DAPK, and GSTP1 Genes in tissue Biopsy and Matched Serum of Advanced-Stage Lung Cancer Patients.

    abstract::Promoter DNA hypermethylation of APC, DAPK, and GSTP1 genes was evaluated in biopsy and matched serum of 160 lung cancer patients and 70 controls. In biopsy, 83.1, 83.1, and 78.1% of lung cancer patients and 72.9, 70, and 70% of controls, while in serum, 52.5, 30.6, and 65.6% of lung cancer patients and 14.3, 18.6, an...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2017.1309547

    authors: Ali A,Kumar S,Kakaria VK,Mohan A,Luthra K,Upadhyay AD,Guleria R

    更新日期:2017-07-03 00:00:00

  • Association between interleukin-8 -251A/T polymorphism and risk of lung cancer: a meta-analysis.

    abstract::This study is to evaluate the association between IL-8 -251A/T polymorphism and lung cancer risk in diverse populations. We performed a meta-analysis of six case-control studies that included 3,265 lung-cancer cases and 3,607 case-free controls. Overall, results showed that the IL-8 -251A/T polymorphism was not associ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,meta分析

    doi:10.3109/07357907.2014.964410

    authors: Gao P,Zhao H,You J,Jing F,Hu Y

    更新日期:2014-12-01 00:00:00

  • Digital dermatoglyphics in mammary cancer.

    abstract::Fingerprints from 200 women with histologically proven breast cancer (case group) were compared to fingerprints from 138 women with no history of any malignant disease (control group). Of the patterns analyzed, four were significantly associated with breast cancer: accidentals, transitionals, angled ulnar loops, and h...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077025

    authors: Bierman HR,Faith MR,Stewart ME

    更新日期:1988-01-01 00:00:00

  • Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue.

    abstract::High-dose acetaminophen (HDAC) produces hepatocellular necrosis and cytotoxic changes in other tissues that express mixed-function-oxidase (MFO) activity. N-acetylcysteine (NAC), administered within 8 hr of HDAC exposure, replenishes reduced glutathione and prevents these effects. Numerous cell culture and animal stud...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909609012140

    authors: Kobrinsky NL,Hartfield D,Horner H,Maksymiuk A,Minuk GY,White DF,Feldstein TJ

    更新日期:1996-01-01 00:00:00

  • Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).

    abstract::Expression of epidermal growth factor and its transmembrane receptor (EGFR) stimulates tumor growth. Matuzumab is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth, and provides a clinical benefit for some patients. The plasma half-life (6-10 days) an...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900701511847

    authors: Schiller JH

    更新日期:2008-02-01 00:00:00

  • Temozolomide treatment of an adult with a relapsing medulloblastoma.

    abstract::Temozolomide is an oral cytotoxic agent that has demonstrated its interest in high grade glioma tumors. This drug can be used either concomitantly with radiotherapy or as chemotherapy. The prognosis of relapsing medulloblastoma is poor and treatment is often difficult, especially after radiotherapy. Here, we report th...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701518164

    authors: Durando X,Thivat E,Gilliot O,Irthum B,Verrelle P,Vincent C,Bay JO

    更新日期:2007-09-01 00:00:00

  • Prognostic significance of extracellular matrix degrading enzymes-cathepsin L and matrix metalloproteases-2 [MMP-2] in human pancreatic cancer.

    abstract::In the present study, we assessed the expression of extracellular matrix (ECM) degrading proteases-cathepsin L and matrix metalloprotease-2 (MMP-2) in pancreatic cancer tissue and correlated their levels with clinicopathological parameters and survival. Both the proteases were expressed in the majority of the tumor ti...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.820318

    authors: Singh N,Das P,Datta Gupta S,Sahni P,Pandey RM,Gupta S,Chauhan SS,Saraya A

    更新日期:2013-08-01 00:00:00

  • Managing patients and families at the ending of life: hospice assumptions, structures, and practice in response to staff stress.

    abstract::Hospice programs do not identify burnout as a significant staff problem, even though there are many significant stressors for staff members doing hospice work. Hospices offer support in a wide variety of ways and settings through their human resources management. All this support is predicated on the assumption that t...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709039724

    authors: Brenner PR

    更新日期:1997-01-01 00:00:00

  • High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients.

    abstract::Ubiquitin ligase Cullin7 has been has been suggested to act as an oncogene in some tumors; however, the prognostic role of Cullin7 has not been evaluated in cancer patients. In this study, we observed that the expression of Cullin7 mRNA was significantly higher in epithelial ovarian cancer (EOC) compared with normal o...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2015.1114123

    authors: Xi J,Zeng ST,Guo L,Feng J

    更新日期:2016-01-01 00:00:00

  • Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis.

    abstract::The expression of the plasma membrane Ca(2+) ATPase (PMCA) was analyzed in a series of 84 formalin-fixed and paraffin embedded colon samples including normal mucosa (n = 32), adenoma (n = 19), adenocarcinoma (n = 27), and lymph node metastasis (n = 6) using (i) immunohistochemistry, (ii) mRNA in situ hybridization, an...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.657817

    authors: Rüschoff JH,Brandenburger T,Strehler EE,Filoteo AG,Heinmöller E,Aumüller G,Wilhelm B

    更新日期:2012-05-01 00:00:00

  • Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer.

    abstract:BACKGROUND:Although treatment-related lymphopenia (TRL) is common in many cancers no data exists in rectal cancer. METHODS:Serial lymphocyte counts were analyzed retrospectively in patients with newly diagnosed rectal cancer, serial blood counts, and complete records at Johns Hopkins Hospital. RESULTS:Fifty-seven pat...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1499028

    authors: Campian JL,Ye X,Sarai G,Herman J,Grossman SA

    更新日期:2018-01-01 00:00:00

  • Late infections following splenectomy in Hodgkin's disease.

    abstract::Here 145 reported post-splenectomy infections in 115 patients with Hodgkin's disease are reviewed. Such infections can occur at any age (median age 19.8 years) and the interval from splenectomy to the infection is quite variable (median 21.9 months). Most infections are present clinically as pneumonia, septicemia, men...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908309040933

    authors: Rosner F,Zarrabi MH

    更新日期:1983-01-01 00:00:00

  • Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects.

    abstract::Tamoxifen is a first targeted drug that continues to be the gold standard in treatment of estrogen receptor positive breast cancer for almost 50 years. The current review is an update of the paper published in 2012. We provide the new data on the tamoxifen targets that are the key points of signaling cascades activati...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2018.1453933

    authors: Bogush TA,Polezhaev BB,Mamichev IA,Bogush EA,Polotsky BE,Tjulandin SA,Ryabov AB

    更新日期:2018-04-21 00:00:00

  • Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.

    abstract::The interaction of 5-fluorouracil and cyclophosphamide in the treatment of L1210 and P388 leukemias was studied using response surface methodology. Single dose treatment of each drug was administered simultaneously or with a 24-hr interval between 5-fluorouracil and cyclophosphamide to the advanced tumors or at variou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908709020311

    authors: Wampler GL,Carter WH Jr,Campbell ED

    更新日期:1987-01-01 00:00:00

  • Investigation of Human Cytomegalovirus and Human Papillomavirus in Glioma.

    abstract::The study investigated the human cytomegalovirus (HCMV) and human papillomavirus (HPV) in gliomas. A retrospective study was conducted on 112 samples. HCMV was investigated by PCR, in situ hybridization (ISH) and immunohistochemistry. HPV was tested by PCR and DNA ISH. HCMV was identified in 60 gliomas, including 55 G...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1793352

    authors: Limam S,Missaoui N,Hmissa S,Yacoubi MT,Krifa H,Mokni M,Selmi B

    更新日期:2020-08-01 00:00:00

  • Activated PKCalpha/ERK1/2 signaling inhibits tamoxifen-induced apoptosis in C6 cells.

    abstract::Data have shown that tamoxifen (TAM) can be used to treat not only breast cancer with positive estrogen receptor (ER), but also negative ER including human glioma. However, the molecular mechanism of this drug against different kinds of cancers remains to be elucidated. In this study, we provided the evidence that PKC...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802672720

    authors: Tian F,Wu H,Li Z,Wang N,Huang J,Li C,Xie F

    更新日期:2009-08-01 00:00:00

  • Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells.

    abstract::Drug resistance to TKIs and the existance of CML leukemia stem cells is an urgent problem. In this study, we demonstrate that quinacrine (QC) induces apoptosis in BCR-ABL positive CML and acute lymphoblastic leukemia (ALL) cells. Interestingly, QC inhibits the colony formation of primary CD34+ progenitor/stem leukemia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1630633

    authors: Lei H,Tu Y,Yang L,Jin J,Luo H,Xu H,Kang J,Zhou L,Wu Y

    更新日期:2019-01-01 00:00:00

  • 8-Cl-cAMP affects glioma cell-cycle kinetics and selectively induces apoptosis.

    abstract::8-Chloro-cyclic-adenosine-3',5'-monophosphate (8-Cl-cAMP), a site-selective synthetic cyclic adenosine 3',5'-monophosphate (cAMP) analog exhibits growth inhibition in a broad spectrum of human cancer lines. However, detailed studies on the effects exerted by cAMP analogs on cell-cycle kinetics have been lacking. We ha...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120005913

    authors: Grbovic O,Jovic V,Ruzdijic S,Pejanovic V,Rakic L,Kanazir S

    更新日期:2002-01-01 00:00:00

  • Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells.

    abstract::We hypothesized that co-targeting the epidermal growth factor receptor (EGFR) and Src with the EGFR inhibitor gefitinib and the Src inhibitor AZD0530 would increase growth inhibition and impede migration. Cells overexpressing EGFR were more sensitive to gefitinib than cells expressing mutated EGFR or normal levels of ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802570759

    authors: Andersen P,Villingshøj M,Poulsen HS,Stockhausen MT

    更新日期:2009-02-01 00:00:00

  • Vinorelbine (Navelbine): a third-generation vinca alkaloid.

    abstract::The vinca alkaloids represent one of the oldest classes of antineoplastic agents used in humans with a wide spectrum of activity against both animal and human tumors. These agents are known to inhibit microtubule polymerization. Vinorelbine is a semisynthetic analog that reached clinical trial on the basis of less pre...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909709047587

    authors: Budman DR

    更新日期:1997-01-01 00:00:00

  • Alterations in self-perceptions among adolescent cancer survivors.

    abstract::Psychosocial adjustment in adolescent cancer survivors has been documented to be quite variable. Factors mediating adjustment need to be identified. The current study is an exploration of the impact that cancer diagnosis and treatment has on adolescent's self-perceptions and the role this has in mediating adjustment i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909109018956

    authors: Smith K,Ostroff J,Tan C,Lesko L

    更新日期:1991-01-01 00:00:00

  • Synergistic Effects of PI3K and c-Myc Co-targeting in Acute Leukemia: Shedding New Light on Resistance to Selective PI3K-δ Inhibitor CAL-101.

    abstract::Enthusiasms into the application of PI3K-δ inhibitor CAL-101 has been muted due to the over-activation of compensatory molecules. Our results delineated that c-Myc suppression using 10058-F4 enhanced CAL-101 cytotoxicity in less sensitive cells through different mechanisms based on p53 status; while CAL-101-plus-10058...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1651328

    authors: Riyahi N,Safaroghli-Azar A,Sheikh-Zeineddini N,Sayyadi M,Bashash D

    更新日期:2019-01-01 00:00:00

  • Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy: a strategy for maintaining dose intensity.

    abstract::Multifractionated dosing (MFD) schedules for chemotherapy administration such as weekly or twice weekly administration are intended to maximize dose intensity while minimizing toxicity, but the cumulative drug effect may result in neutropenia necessitating interruption of dose fractions and thereby compromising dose i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909909032865

    authors: Lokich J

    更新日期:1999-01-01 00:00:00

  • The effect of castration on the synthesis and secretion of proteins in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.

    abstract:UNLABELLED:The effect of castration on the incorporation of [35S]methionine into secreted proteins in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors, was investigated. Biopsy specimens were obtained from 19 tumors, 0, 24, 48, 72, and 96 h after castration. In 14 tumors, castration induced an increase ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909209032762

    authors: Geier A,Hemi R,Beery R,Lunenfeld B

    更新日期:1992-01-01 00:00:00

  • Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.

    abstract:OBJECTIVE:Patients with systemic malignancies have substantial quantities of tumor-specific DNA in their plasma which may serve as a potential biomarker for tumor burden. This approach has not been studied in gliomas. METHODS:Methylation specific polymerase chain reaction (MSP) was used to determine the methylation st...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900500449546

    authors: Weaver KD,Grossman SA,Herman JG

    更新日期:2006-02-01 00:00:00

  • In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.

    abstract::In vivo and in vitro observations of cellular immune response in 70 patients with squamous cell cancer of the oral cavity and in 40 age-matched normal controls, were made using delayed hypersensitivity responses to DNCB, PPD, and Candida albicans extract (Dermatophytin 'O'), absolute lymphocyte counts, absolute T-cell...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609018450

    authors: Das SN,Khanna NN,Khanna S

    更新日期:1986-01-01 00:00:00

  • 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.

    abstract::The expression of p53-target genes encoding the proapoptotic factor Noxa, but not PUMA, was not induced by p53 in HCT116 and SW480 cells, which show resistance to apoptosis in response to p53 overexpression. The lack of p53 inducibility of Noxa was restored by treatment with the DNA methyltransferase inhibitor 5-Aza-2...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701840212

    authors: Yagi S,Oda-Sato E,Uehara I,Asano Y,Nakajima W,Takeshita T,Tanaka N

    更新日期:2008-08-01 00:00:00

  • Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.

    abstract::To identify the relevant CpG sites as molecular markers, for the diagnosis and to distinguish the indolent and aggressive prostate tumors, we have determined the methylation status of 8 genes, including FLNC, EFS, ECRG4, RARB2, PITX2, GSTP1, PDLIM4, and KCNMA1 in 32 nonrecurrent, 32 recurrent primary prostate tumors, ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802620794

    authors: Vanaja DK,Ehrich M,Van den Boom D,Cheville JC,Karnes RJ,Tindall DJ,Cantor CR,Young CY

    更新日期:2009-06-01 00:00:00

  • Progesterone challenge test in postmenopausal women with pathological endometrium.

    abstract::Cytosolic and nuclear progesterone receptor levels (RPC, RPN) were measured in normal and in pathological human endometria after single-dose progesterone injection 1-3 h before tissue collection (test subjects) and the results compared to those obtained in controls (no progesterone treatment). In test cases of late pr...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809082116

    authors: Gorodeski IG,Geier A,Lunenfeld B,Bahary CM

    更新日期:1988-01-01 00:00:00